Literature DB >> 29846881

Are iatrogenic renal artery pseudoaneurysms more challenging to embolize when associated with an arteriovenous fistula?

Giulio Barbiero1, Stefano Groff2, Michele Battistel2, Andrea Casarin3, Alessandro Guarise3, Diego Miotto2.   

Abstract

BACKGROUND: Iatrogenic injuries of the renal artery include pseudoaneurysms (PSA) and pseudoaneurysms with arteriovenous fistula (PSA + AVF). They can cause hematuria, anemization and flank pain. Endovascular treatment is recommended due to its effectiveness.
OBJECTIVE: To assess the potential difference between the embolization of iatrogenic renal PSA and iatrogenic renal PSA + AVF, in terms of technical and clinical success rate, procedure complexity and impact on the renal function.
METHODS: We retrospectively reviewed 30 embolization procedures of iatrogenic renal PSA and renal PSA + AVF in 27 patients in two centers between December 2006 and February 2017, comparing technical and clinical success rate, total procedural time, creatinine before and after the procedure and parenchymal ischemic area after the procedure. All patients underwent CT before embolization procedure and different embolization materials were used.
RESULTS: We identified 15 iatrogenic renal PSA and 15 iatrogenic renal PSA + AVF (causes: 23 nephron-sparing surgery, 2 nephrostomies, 1 lithotripsy, 1 ureteroscopic pyelolithotomy, 1 renal biopsy). Microcoils were used in 21 cases, microcoils and Spongostan in 3 cases, microcoils and controlled-release microcoils in 4 cases and controlled-release microcoils in 1 case. No significant statistical differences were found in the comparison of technical and clinical success rate, total procedural time, creatinine and parenchymal ischemic area after the procedure.
CONCLUSIONS: Transarterial embolization can be considered as the first-line treatment for renal artery iatrogenic lesions, considering its effectiveness. No statistical significant differences were found in the comparison of the embolization procedures of iatrogenic renal PSA and PSA + AVF.

Entities:  

Keywords:  Arteriovenous fistula; Endovascular treatment; Iatrogenic pseudoaneurysm; Transarterial embolization

Mesh:

Year:  2018        PMID: 29846881     DOI: 10.1007/s11547-018-0906-3

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  26 in total

1.  Selective arterial embolization of life-threatening renal hemorrhage in four patients after partial nephrectomy.

Authors:  H R Tinto; M Di Primio; L Tselikas; A Palomera Rico; O Pellerin; J-Y Pagny; M Sapoval
Journal:  Diagn Interv Imaging       Date:  2014-03-15       Impact factor: 4.026

2.  Renal artery pseudoaneurysm after laparoscopic partial nephrectomy for renal cell carcinoma in a solitary kidney.

Authors:  Hiromitsu Negoro; Mutsushi Kawakita; Yoichi Koda
Journal:  Int J Urol       Date:  2005-07       Impact factor: 3.369

3.  Percutaneous embolization of iatrogenic arterial kidney injuries: safety, efficacy, and impact on blood pressure and renal function.

Authors:  Karl Sam; Gérald Gahide; Gilles Soulez; Marie-France Giroux; Vincent L Oliva; Pierre Perreault; Louis Bouchard; Patrick Gilbert; Eric Therasse
Journal:  J Vasc Interv Radiol       Date:  2011-08-15       Impact factor: 3.464

Review 4.  Renal pseudoaneurysm: an overview.

Authors:  Tin C Ngo; J Joy Lee; Mark L Gonzalgo
Journal:  Nat Rev Urol       Date:  2010-10-12       Impact factor: 14.432

5.  Endovascular management of iatrogenic native renal arterial pseudoaneurysms.

Authors:  Onur Sildiroglu; Wael E Saad; Klaus D Hagspiel; Alan H Matsumoto; Ulku Cenk Turba
Journal:  Cardiovasc Intervent Radiol       Date:  2011-12-15       Impact factor: 2.740

6.  Management of post-biopsy renal allograft arteriovenous fistulas with selective arterial embolization: immediate and long-term outcomes.

Authors:  R Loffroy; B Guiu; A Lambert; C Mousson; Y Tanter; L Martin; J-P Cercueil; D Krausé
Journal:  Clin Radiol       Date:  2008-02-20       Impact factor: 2.350

Review 7.  Incidence of renal artery pseudoaneurysm following open and minimally invasive partial nephrectomy: a systematic review and comparative analysis.

Authors:  Samay Jain; Themba Nyirenda; Jennifer Yates; Ravi Munver
Journal:  J Urol       Date:  2012-12-03       Impact factor: 7.450

8.  Vascular injuries after percutaneous renal procedures: treatment by transcatheter embolization.

Authors:  Claudio Vignali; Simone Lonzi; Irene Bargellini; Roberto Cioni; Pasquale Petruzzi; Davide Caramella; Carlo Bartolozzi
Journal:  Eur Radiol       Date:  2003-11-19       Impact factor: 5.315

9.  Renal artery embolization for the treatment of renal artery pseudoaneurysm following partial nephrectomy.

Authors:  Cara Irwine; Dennis Kay; David Kirsch; James Michael Milburn
Journal:  Ochsner J       Date:  2013

10.  Management of iatrogenic renal arteriovenous fistula and renal arterial pseudoaneurysm by transarterial embolization: A single center analysis and outcomes.

Authors:  Hongjie Guo; Chengen Wang; Min Yang; Xiaoqiang Tong; Jian Wang; Haitao Guan; Li Song; Yinghua Zou
Journal:  Medicine (Baltimore)       Date:  2017-10       Impact factor: 1.889

View more
  3 in total

1.  Endovascular Occlusion of a Renal Arteriovenous Fistula with Renal Vein Aneurysm Formation for Rupture Prevention.

Authors:  Yae Hyun Rhee; Lucas Busch; Roberto Sansone; Neslihan Ertas; Nikolaos Floros; Hubert Schelzig; Joscha Mulorz; Markus Udo Wagenhäuser
Journal:  Case Rep Vasc Med       Date:  2019-10-31

Review 2.  A rare case of non-traumatic intrasplenic pseudoaneurysms in a patient with acute T-cell lymphoblastic leukemia.

Authors:  Margherita Trinci; Carlo Giangregorio; Giovanna Calabrese; Pierfrancesco Ottaviani; Pascale Riu; Michele Galluzzo; Vittorio Miele
Journal:  J Ultrasound       Date:  2019-08-01

3.  Value of Angioembolization in the Treatment of Iatrogenic Renal Vascular Injury Assisted by 3-Dimensional Digital Subtraction Angiography.

Authors:  Xin Liao; Hao Xu; Fan Liu; Xuli Min; Yugen Li; Lin Yang; Yongjun Ren
Journal:  Med Sci Monit       Date:  2020-09-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.